Novelos Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Novelos Therapeutics Inc
CIK #0001279704
EDGAR Form CIK 2011 - 2026
10-K [0001279704]
10-Q [0001279704]
3 [0001279704]
4 [0001279704]
5 [0001279704]
8-K [0001279704]
D [0001279704]
SC 13D [0001279704]
SC 13G [0001279704]
Form 13D/13G Filer Form 13D/13G Subject Filed
Janus Henderson Group PLC Cellectar Biosciences Inc [2026-06-05]
Stonepine Capital Management LLC Cellectar Biosciences Inc [2026-05-11]
Bleichroeder LP Cellectar Biosciences Inc [2025-11-14]
Hexstone Capital LLC Cellectar Biosciences Inc [2025-08-08]
Intracoastal Capital LLC Cellectar Biosciences Inc [2025-07-08]
Nantahala Capital Management LLC Cellectar Biosciences Inc [2024-02-14]
ADAR1 Partners LP Cellectar Biosciences Inc [2024-01-31]
Lytton Laurence W Cellectar Biosciences Inc [2023-12-07]
Hirschman Orin Cellectar Biosciences Inc [2023-12-05]
Lincoln Park Capital Fund LLC Cellectar Biosciences Inc [2022-10-25]
Rosalind Advisors Inc Cellectar Biosciences Inc [2021-07-08]
Consonance Capital Management LP Cellectar Biosciences Inc [2021-02-17]
Consonance Capital Management LP Cellectar Biosciences Inc [2021-02-16]
SIO Capital Management LLC Cellectar Biosciences Inc [2021-02-16]
Lincoln Park Capital Fund LLC Cellectar Biosciences Inc [2020-07-13]
Armistice Capital LLC Cellectar Biosciences Inc [2020-06-12]
Lytton Laurence W Cellectar Biosciences Inc [2020-06-12]
Hirschman Orin Cellectar Biosciences Inc [2020-06-10]
North Sound Trading LP Cellectar Biosciences Inc [2019-06-28]
Boxer Capital LLC Cellectar Biosciences Inc [2019-05-28]
Tang Capital Partners LP Cellectar Biosciences Inc [2019-05-28]
Anson Funds Management LP Cellectar Biosciences Inc [2019-05-28]
Intracoastal Capital LLC Cellectar Biosciences Inc [2019-05-24]
UBS Group AG Cellectar Biosciences Inc [2019-02-15]
Greenway Properties Inc Cellectar Biosciences Inc [2016-07-25]
Hertzberg Richard Cellectar Biosciences Inc [2016-06-02]
Wisconsin Alumni Research Foundation Cellectar Biosciences Inc [2016-04-25]
FMR LLC Cellectar Biosciences Inc [2016-04-11]
AWM Investment Company Inc Cellectar Biosciences Inc [2015-01-29]
Marxe Austin W & Greenhouse David M Cellectar Biosciences Inc [2014-09-09]
Cormorant Asset Management LLC Cellectar Biosciences Inc [2014-09-02]
Sabby Management LLC Cellectar Biosciences Inc [2014-08-20]
[2013-03-14]
Form 3/4/5 Subject 2011 - 2026
Novelos Therapeutics Inc
NEIS John
Gu Andrew
Longcor Jarrod
Swirsky Douglas J
Loren Stefan
Kolean Chad J
Driscoll Frederick W
Chanan-Khan Asher
Caruso James V
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Novelos Therapeutics Inc CLRB
Common Stock
2025-12-12 Sell 198 $3.70 733
Novelos Therapeutics Inc CLRB
Warrants · derivative
2025-07-02 Buy 10,000 $0.01 100
Novelos Therapeutics Inc CLRB
Common Stock
2025-07-02 Buy 10,000 $4.99 49,900
Novelos Therapeutics Inc CLRB
Common Stock
2025-07-02 Buy 10,000 $4.99 49,900
Novelos Therapeutics Inc CLRB
Warrants · derivative
2025-07-02 Buy 5,000 $0.01 50
Novelos Therapeutics Inc CLRB
Common Stock
2025-07-02 Buy 5,000 $4.99 24,950
Novelos Therapeutics Inc CLRB
Warrants · derivative
2025-07-02 Buy 10,000 $0.01 100
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2025-02-14 Grant 60,000 $0.00
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2025-02-14 Grant 900,000 $0.00
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2025-02-14 Grant 90,000 $0.00
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2025-02-14 Grant 60,000 $0.00
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2025-02-14 Grant 60,000 $0.00
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2025-02-14 Grant 500,000 $0.00
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2025-02-14 Grant 290,000 $0.00
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2025-02-14 Grant 60,000 $0.00
Novelos Therapeutics Inc CLRB
Common Stock
2025-01-10 Buy 30,000 $0.28 8,400
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2024-06-14 Grant 260,000 $0.00
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2024-06-14 Grant 500,000 $0.00
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2024-06-14 Grant 900,000 $0.00
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
2024-06-14 Grant 290,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com